takeover target yes - will it be sold? no way, page-5

At current prices, I honestly can't see why Dr Reddy's wouldn't try to take ACL over... or why (insert name of any large pharma worth their salt) wouldn't consider a hasty opportunistic bid.

Reddy's in particular must relish the thought of retaining the other 50-60% of US Fonda profits, and not paying out any royalties from Europe and ROW in the future. With probably 4-5 years of unrestricted "only generic" share of those markets - it's got to be a compelling case when there's near certainty of being able to pay off the entire investment over that period... and all further revenues, pipeline drug opportunities and VAST platform thrown in as a bonus.

I do share people's annoyance that people can take a risk-free position at, or around, the pre-approval price but nothing about the current share price actually bothers me more than the fact that I can't see ACL existing for long as it's own entity if it stays at this level.

I bought more at 75c last week in disbelief as they dropped, and then a few more yesterday at 69c as my jaw hit the table. I probably shouldn't be shocked but I am. I probably shouldn't still be buying (given the % of my portfolio they make up) but I am. Could be a mistake but I can do basic maths and until something changes the relatively simple formula, they represent excellent value IMO.